Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
319 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| TPST | Tempest Therapeutics, Inc. | Oncology | $17.86M | $1.08 | −91.17% | +24.00% |
| AKTX | Akari Therapeutics, Plc | Oncology | $17.72M | $9.10 | −81.65% | +7.95% |
| ABERA.ST | Abera Bioscience AB | Oncology | $17.69M | 8.18 SEK | −18.61% | −2.62% |
| B8FK.DE | Biofrontera AG | Oncology |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| $17.36M |
| 2.53 EUR |
| −14.53% |
| −0.78% |
| 4882.T | Perseus Proteomics Inc. | Oncology | $17.25M | 149.00 JPY | −58.73% | +4.93% |
| MDCX | Medicus Pharma Ltd. | Oncology | $16.96M | $0.27 | −91.20% | −4.11% |
| RAD.AX | Radiopharm Theranostics Limited | Oncology | $16.95M | 0.01 AUD | −75.00% | −28.57% |
| CTXR | Citius Pharmaceuticals, Inc. | Oncology | $16.57M | $0.58 | −73.65% | +15.88% |
| LSTA | Lisata Therapeutics, Inc. | Oncology | $15.68M | $1.74 | −65.68% | +50.00% |
| INTS | Intensity Therapeutics, Inc. | Oncology | $14.79M | $4.53 | −89.59% | −0.44% |
| ACTI.ST | Active Biotech AB (publ) | Oncology | $14.50M | 5.50 SEK | −68.49% | +6.38% |
| PHIO | Phio Pharmaceuticals Corp. | Oncology | $13.94M | $1.20 | −71.36% | +18.81% |
| GTBP | GT Biopharma, Inc. | Oncology | $13.52M | $0.29 | −78.82% | −8.49% |
| PDSB | PDS Biotechnology Corporation | Oncology | $12.49M | $0.22 | −85.60% | −67.70% |
| CRTX.L | CRISM Therapeutics Corporation | Oncology | $12.38M | 11.50 GBP | −37.84% | +21.05% |
| APRE | Aprea Therapeutics, Inc. | Oncology | $12.34M | $0.98 | −42.35% | +59.61% |
| BLRX | BioLineRx Ltd. | Oncology | $11.79M | $2.70 | −40.79% | −3.91% |
| MBRX | Moleculin Biotech, Inc. | Oncology | $11.69M | $0.60 | −96.19% | −72.60% |
| TOVX | Theriva Biologics, Inc. | Oncology | $11.16M | $0.24 | −71.72% | +15.81% |
| 0NWK.L | Valerio Therapeutics Société anonyme | Oncology | $10.08M | 0.86 EUR | −5.42% | +8.09% |
| LNAI | Lunai Bioworks Inc. | Oncology | $9.97M | $2.20 | −89.62% | −1.79% |
| PUR.WA | MultiQure S.A. | Oncology | $9.70M | 3.05 PLN | −60.75% | +40.23% |
| 4598.T | Delta-Fly Pharma, Inc. | Oncology | $9.28M | 104.00 JPY | −85.14% | +9.47% |
| IMNN | Imunon, Inc. | Oncology | $9.15M | $1.63 | −76.58% | +6.54% |
| XBIO | Xenetic Biosciences, Inc. | Oncology | $9.04M | $3.86 | −72.29% | +54.40% |
| CNSP | CNS Pharmaceuticals, Inc. | Oncology | $8.48M | $5.44 | −48.62% | +7.30% |
| AIM | AIM ImmunoTech Inc. | Oncology | $7.61M | $0.25 | −91.35% | +4.17% |
| PAB.AX | Patrys Limited | Oncology | $7.56M | 0.03 AUD | −42.31% | −23.08% |
| BOLT | Bolt Biotherapeutics, Inc. | Oncology | $7.55M | $3.92 | −45.56% | −2.49% |
| CURX | Curanex Pharmaceuticals Inc | Oncology | $7.21M | $4.60 | −49.89% | +2223.23% |
| CANF | Can-Fite BioPharma Ltd. | Oncology | $7.11M | $3.32 | −75.22% | +5.06% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | Oncology | $7.05M | 0.32 EUR | −65.33% | +2.57% |
| CHOSA.ST | Chosa Oncology AB | Oncology | $7.01M | 0.73 SEK | −66.91% | −14.15% |
| ITOC | iTonic Holdings Ltd. | Oncology | $6.75M | $0.29 | −75.44% | +11.89% |
| NCNA | NuCana plc | Oncology | $6.37M | $1.53 | −78.81% | +18.60% |
| LIMN | Liminatus Pharma, Inc. | Oncology | $6.19M | $4.41 | −52.07% | +4140.38% |
| PCSA | Processa Pharmaceuticals, Inc. | Oncology | $5.95M | $2.13 | −85.05% | −30.16% |
| KAPA | Kairos Pharma, Ltd. | Oncology | $5.88M | $0.26 | −87.68% | −15.58% |
| NFX.L | Nuformix plc | Oncology | $5.85M | 0.16 GBP | −71.35% | +6.71% |
| 0GP7.L | Medivir AB (publ) | Oncology | $5.78M | 2.03 SEK | −29.39% | +6.77% |
| PER.AX | PERCHERON FPO [PER] | Oncology | $5.45M | 0.01 AUD | −54.55% | +66.67% |
| BCAB | BioAtla, Inc. | Oncology | $5.20M | $3.12 | −95.64% | −11.61% |
| HCWB | HCW Biologics Inc. | Oncology | $4.96M | $2.70 | −63.27% | +4.45% |
| APS.TO | Aptose Biosciences Inc | Oncology | $4.41M | 2.40 CAD | −1.64% | 0.00% |
| APVO | Aptevo Therapeutics Inc. | Oncology | $4.34M | $2.41 | −95.06% | −42.76% |
| OSRH | OSR Health, Inc. | Oncology | $4.09M | $0.17 | −86.45% | −63.24% |
| CRIS | Curis, Inc. | Oncology | $3.86M | $1.54 | −86.49% | −68.12% |
| RDHL | RedHill Biopharma Ltd. | Oncology | $3.74M | $0.62 | −77.95% | −15.71% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | Oncology | $3.53M | 0.16 SEK | −41.60% | +30.42% |
| CLDI | Calidi Biotherapeutics, Inc. | Oncology | $3.49M | $1.35 | −32.50% | −21.14% |
| GOVX | GeoVax Labs, Inc. | Oncology | $3.34M | $0.63 | −96.85% | −13.33% |
| ARTL | Artelo Biosciences, Inc. | Oncology | $3.27M | $0.71 | −97.55% | −19.25% |
| IVX.AX | Invion Limited | Oncology | $2.83M | 0.04 AUD | −74.29% | −18.18% |
| PPBT | Purple Biotech Ltd | Oncology | $2.81M | $1.73 | −92.79% | +26.28% |
| VAL.L | ValiRx plc | Oncology | $2.78M | 0.16 GBP | −81.74% | +3.33% |
| NXTS | Nexentis Technologies Inc. | Oncology | $2.73M | $1.88 | −96.80% | +21.29% |
| RNAZ | TransCode Therapeutics, Inc. | Oncology | $2.48M | $2.34 | −88.85% | −53.20% |
| PPCB | Propanc Biopharma, Inc. | Oncology | $2.44M | $1.07 | −98.93% | −11.57% |
| 0RK9.L | Alligator Bioscience AB (publ) | Oncology | $2.11M | 0.03 SEK | −99.38% | +10.16% |
| NX1.AX | Nexalis Therapeutics Limited | Oncology | $2.00M | 0.01 AUD | −63.33% | 0.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.